世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000036620

顔面注射剤市場-規模、シェア、動向分析レポート、およびセグメント予測、2023〜2030

Grand View Research Inc.

Facial Injectable Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2023- 2030

発刊日 2023/11

言語英語

体裁PDF/172ページ

ライセンス/価格172ページ

0000036620

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

顔面注射剤の市場規模、シェア、動向分析レポート:製品別(コラーゲンおよびアクリル樹脂、マイクロスフィア、ヒアルロン酸)、用途別(フェイスライン矯正、フェイスリフト)、エンドユース別、地域別、およびセグメント予測2023〜2030年

顔面注射剤市場の規模と動向

世界の顔面注射市場規模は2022年に102億2,000万ドルと推定され、2023年から2030年にかけて12.0%のCAGRで成長すると予想されます。近年、消費者の外見への関心の高まりにより、顔面注射剤の需要が増加しています。老化のさまざまな兆候に影響されやすい人口が多数存在することも、世界的に顔面注射剤の需要を高めています。顔のハリの低下によるシワやたるみ、シミなどの老化のサインは、25歳〜30歳くらいから現れ始め、30歳〜65歳にかけて顕著になります。市場の主要企業が主催するさまざまな美容キャンペーンによる低侵襲処置に関する意識の高まりも、市場の推進要因です。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.6. Data for primary interviews in North America
1.3.7. Data for primary interviews in Europe
1.3.8. Data for primary interviews in Asia Pacific
1.3.9. Data for primary interviews in Latin America
1.3.10. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Approach 1: Commodity flow analysis
1.6.2. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Global Facial Injectable Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing aging population
3.2.1.2. Increasing awareness and acceptance of aesthetic treatments
3.2.1.3. Technological advancements
3.2.2. Market Restraint Analysis
3.2.2.1. Regulatory constrains
3.2.2.2. High cost of procedures
3.3. Facial Injectable Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Facial Injectable Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Collagen & PMMA Microspheres
4.1.2. Hyaluronic Acid (HA)
4.1.3. Botulinum Toxin Type A
4.1.4. Calcium Hydroxylapatite (CaHA)
4.1.5. Poly-L-lactic Acid (PLLA)
4.1.6. Others
4.2. Product Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Facial Injectable Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Collagen & PMMA Microspheres
4.5.1.1. Collagen & PMMA Microspheres market estimates and forecast 2018 to 2030 (USD Billion)
4.5.2. Hyaluronic Acid (HA)
4.5.2.1. Hyaluronic Acid (HA) market estimates and forecast 2018 to 2030 (USD Billion)
4.5.3. Calcium Hydroxylapatite (CaHA)
4.5.3.1. Calcium Hydroxylapatite (CaHA) market estimates and forecast 2018 to 2030 (USD Billion)
4.5.4. Poly-L-lactic Acid (PLLA)
4.5.4.1. Poly-L-lactic Acid (PLLA) market estimates and forecast 2018 to 2030 (USD Billion)
4.5.5. Others
4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Facial Injectable Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Facial Line Correction
5.1.2. Lip Augmentation
5.1.3. Face Lift
5.1.4. Acne Scar Treatment
5.1.5. Lipoatrophy Treatment
5.1.6. Others
5.2. Application Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Facial Injectable Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Facial Line Correction
5.5.1.1. Facial Line Correction market estimates and forecast 2018 to 2030 (USD Billion)
5.5.2. Lip Augmentation
5.5.2.1. Lip Augmentation market estimates and forecast 2018 to 2030 (USD Billion)
5.5.3. Face Lift
5.5.3.1. Face Lift market estimates and forecast 2018 to 2030 (USD Billion)
5.5.4. Acne Scar Treatment
5.5.4.1. Acne Scar Treatment market estimates and forecast 2018 to 2030 (USD Billion)
5.5.5. Lipoatrophy Treatment
5.5.5.1. Lipoatrophy Treatment market estimates and forecast 2018 to 2030 (USD Billion)
5.5.6. Others
5.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Facial Injectable Market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Medspas
6.1.2. Dermatology Clinics
6.1.3. Hospitals
6.2. End-use Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Injectable Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Medspas
6.5.1.1. Medspas market estimates and forecast 2018 to 2030 (USD Billion)
6.5.2. Dermatology Clinics
6.5.2.1. Dermatology Clinics market estimates and forecast 2018 to 2030 (USD Billion)
6.5.3. Hospitals
6.5.3.1. Hospitals market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 7. Facial Injectable Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. North America Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.2. U.S.
7.7.2.1. U.S. Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.2.2. Key Country Dynamics
7.7.2.3. Competitive Scenario
7.7.2.4. Regulatory Framework
7.7.3. Canada
7.7.3.1. Canada Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.3.2. Key Country Dynamics
7.7.3.3. Competitive Scenario
7.7.3.4. Regulatory Framework
7.8. Europe
7.8.1. Europe Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.2. UK
7.8.2.1. UK Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.2.2. Key Country Dynamics
7.8.2.3. Competitive Scenario
7.8.2.4. Regulatory Framework
7.8.3. Germany
7.8.3.1. Germany Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.3.2. Key Country Dynamics
7.8.3.3. Competitive Scenario
7.8.3.4. Regulatory Framework
7.8.4. France
7.8.4.1. France Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.4.2. Key Country Dynamics
7.8.4.3. Competitive Scenario
7.8.4.4. Regulatory Framework
7.8.5. Italy
7.8.5.1. Italy Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.5.2. Key Country Dynamics
7.8.5.3. Competitive Scenario
7.8.5.4. Regulatory Framework
7.8.6. Spain
7.8.6.1. Spain Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.6.2. Key Country Dynamics
7.8.6.3. Competitive Scenario
7.8.6.4. Regulatory Framework
7.8.7. Sweden
7.8.7.1. Sweden Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.7.2. Key Country Dynamics
7.8.7.3. Competitive Scenario
7.8.7.4. Regulatory Framework
7.8.8. Norway
7.8.8.1. Norway Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.8.2. Key Country Dynamics
7.8.8.3. Competitive Scenario
7.8.8.4. Regulatory Framework
7.8.9. Denmark
7.8.9.1. Denmark Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.9.2. Key Country Dynamics
7.8.9.3. Competitive Scenario
7.8.9.4. Regulatory Framework
7.9. Asia Pacific
7.9.1. Asia Pacific Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.2. China
7.9.2.1. China Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.2.2. Key Country Dynamics
7.9.2.3. Competitive Scenario
7.9.2.4. Regulatory Framework
7.9.3. Japan
7.9.3.1. Japan Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.3.2. Key Country Dynamics
7.9.3.3. Competitive Scenario
7.9.3.4. Regulatory Framework
7.9.4. India
7.9.4.1. India Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.4.2. Key Country Dynamics
7.9.4.3. Competitive Scenario
7.9.4.4. Regulatory Framework
7.9.5. Australia
7.9.5.1. Australia Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.5.2. Key Country Dynamics
7.9.5.3. Competitive Scenario
7.9.5.4. Regulatory Framework
7.9.6. Thailand
7.9.6.1. Thailand Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.6.2. Key Country Dynamics
7.9.6.3. Competitive Scenario
7.9.6.4. Regulatory Framework
7.9.7. South Korea
7.9.7.1. South Korea Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.7.2. Key Country Dynamics
7.9.7.3. Competitive Scenario
7.9.7.4. Regulatory Framework
7.10. Latin America
7.10.1. Latin America Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.10.2. Brazil
7.10.2.1. Brazil Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.10.2.2. Key Country Dynamics
7.10.2.3. Competitive Scenario
7.10.2.4. Regulatory Framework
7.10.3. Mexico
7.10.3.1. Mexico Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.10.3.2. Key Country Dynamics
7.10.3.3. Competitive Scenario
7.10.3.4. Regulatory Framework
7.10.4. Argentina
7.10.4.1. Argentina Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.10.4.2. Key Country Dynamics
7.10.4.3. Competitive Scenario
7.10.4.4. Regulatory Framework
7.11. MEA
7.11.1. MEA Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.11.2. Saudi Arabia
7.11.2.1. Saudi Arabia Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.11.2.2. Key Country Dynamics
7.11.2.3. Competitive Scenario
7.11.2.4. Regulatory Framework
7.11.3. South Africa
7.11.3.1. South Africa Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.11.3.2. Key Country Dynamics
7.11.3.3. Competitive Scenario
7.11.3.4. Regulatory Framework
7.11.4. UAE
7.11.4.1. UAE Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.11.4.2. Key Country Dynamics
7.11.4.3. Competitive Scenario
7.11.4.4. Regulatory Framework
7.11.5. Kuwait
7.11.5.1. Kuwait Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.11.5.2. Key Country Dynamics
7.11.5.3. Competitive Scenario
7.11.5.4. Regulatory Framework

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Manufacturers
8.2. Company Profiles (Manufacturers)
8.2.1. Ispen
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Abbvie (Allergen)
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Merz Pharma
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Galderma
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Revance Therapeutics
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Sinclair Pharma
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviations
Table 2 List of Secondary Sources

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Facial Injectable Market: market outlook
Fig. 9 Facial Injectable Market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Global Facial Injectable Market driver impact
Fig. 14 Global Facial Injectable Market restraint impact
Fig. 15 Global Facial Injectable Market strategic initiatives analysis
Fig. 16 Global Facial Injectable Market: Product movement analysis
Fig. 17 Global Facial Injectable Market: Product outlook key takeaways
Fig. 18 Collagen & PMMA Microspheres market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 19 Hyaluronic Acid (HA) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Botulinum Toxin Type A market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 Calcium Hydroxylapatite (CaHA) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 Poly-L-lactic Acid (PLLA) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 Global Facial Injectable Market: Application movement analysis
Fig. 25 Global Facial Injectable Market: Application outlook and key takeaways
Fig. 26 Facial Line Correction market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 Lip Augmentation market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Face Lift market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Acne Scar Treatment Augmentation market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Lipoatrophy Treatment market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 32 Global Facial Injectable Market: End-use movement analysis
Fig. 33 Global Facial Injectable Market: End-use outlook and key takeaways
Fig. 34 Medspas market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 35 Dermatology Clinics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 37 Global Facial Injectable Market: regional movement analysis
Fig. 38 Global Facial Injectable Market: regional outlook and key takeaways
Fig. 39 North America Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 40 U.S. Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 41 Canada Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 42 Europe. Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 43 UK Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 44 Germany Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 45 France Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 46 Italy Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 47 Spain Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 48 Sweden Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 49 Norway Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 50 Denmark Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 51 Asia Pacific Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 52 China Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 53 Japan Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 54 India Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 55 Australia Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 56 Thailand Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 57 South Korea Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 58 Latin America Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 59 Brazil Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 60 Mexico Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 61 Argentina Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 62 Middle East and Africa Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 63 Saudi Arabia Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 64 South Africa Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 65 UAE Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 66 Kuwait Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)

この商品のレポートナンバー

0000036620

TOP